m1774
merck,medsir
['m1774', 'solid tumor', 'medsir']
phase 1 ddriver solid tumours 301 study: m1774, an oral specific atr inhibitor, well tolerated in monotherapy in pts with adv. solid tumors with emerging efficacy mg qd. m1774 will be further investigated in combination with ddris or immuno. talk by #timothyyap #esmo22 
Bring your idea to life??Creating successful IITs & optimal drug development??Medica Scientia Innovation Research????????https://t.co/cciUf0lqpM